ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Key Hearings Scheduled On Cancer Act, Appropriations

January 21, 1977

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

Columbia Formally Names As 21st Comprehensive Center

March 9, 1979

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985